Acadia Pharma Slides Despite Positive Major Depressive Disorder Results
Acadia Pharmaceuticals shares dipped on Wednesday despite announcing positive top-line results from its Clarity mid-stage study in major depressive disorder (MDD).
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 117
Merck Wins Yet Again With New Keytruda Approval
Merck shares were up slightly on Wednesday after the pharma giant gave another key update for its KEYTRUDA line. The firm announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, in…
Why Pfizer Is Tripping Over Itself With Earnings
Pfizer reported mixed quarterly results before the markets opened on Tuesday and shares retreated in the premarket.
Melinta Therapeutics Loses Again Despite Positive Phase 3 Results
Melinta Therapeutics shares dropped on Monday despite the company announcing positive top-line results from its Phase 3 trial of Baxdela (delafloxacin) for the treatment of adult patients with community-acquired bacterial pneumonia.
What to Watch For When Pfizer Reports Tuesday Morning
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology
Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development and commercialization of potential new medicines in the areas of cardio-metabolic disease, neurodegeneration and…
Gilead Stumbles Despite Solid Earnings Beat
Gilead shares retreated on Friday after it reported mixed third-quarter financial results late on Thursday.
Major Pharma Short Sellers Hike Their Bets
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Merck Earnings Reflect Huge Increase in Keytruda Sales, Outlook Raised for FY18
Pharmaceutical maker Merck beat adjusted earnings estimates but missed slightly on revenues when it reported Q3 results Thursday morning. Investors responded positively, however.
Short Sellers Hike Their Bets in Major Biotechs
The October 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market
These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices for worried investors to consider now.
Huge Study Shows American Kids Don’t Get Enough Exercise
A large new study released today shows that American children fall short of the amount of exercise they need each day. The figures vary by both geography and type of exercise.
Are Investors Giving Alexion Enough Credit for Earnings?
Alexion Pharmaceuticals reported better-than-expected quarterly results before the markets opened on Wednesday.
Orchard RX Announces Potential Pricing for IPO
Biopharmaceutical company Orchard RX is offering more than 13 million shares in an initial public offering valued up to more than $245 million.
Pfizer and Bain Capital Partner Up to Tackle CNS Disorders
Pfizer, in collaboration with Bain Capital, announced the creation of Cerevel Therapeutics, a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system.